Skip to main content

FDA & Compliance

First-Time FDA Import of Medical Devices, Step by Step

A complete walkthrough of a first U.S. medical device import: registration, listing, product codes, entry documentation, labeling, UDI and FDA entry review.

11 min readUpdated November 2026

A first medical device import is not a single filing. It is a set of dependencies, and the failures that stall shipments at the port almost always come from one dependency being out of sequence: a registration completed after the entry was filed, a product code that does not match the listing, a label without the required importer statement. Working through the sequence in order removes most of that risk.

Step 1: Establish the U.S. regulatory baseline

Before a commercial invoice exists, confirm what your device is in FDA terms: its classification, its regulation number, its product code, and whether it requires 510(k) clearance, a De Novo grant, a PMA, or is exempt. This determines everything downstream, including whether the device can be imported at all.

  • Identify the product code and classification regulation for the exact device and its accessories.
  • Confirm clearance status and keep the clearance number on file.
  • Register the foreign establishment and list the device in FDA’s systems.
  • Designate a U.S. Agent and document the designation.

Step 2: Build the entry file

FDA entry review compares the shipment paperwork against your registration and listing. Mismatches are the most common cause of holds, so the file should be assembled as one consistent package rather than gathered from different departments on the day of shipping.

  • Commercial invoice and packing list with quantities, values and country of origin.
  • Bill of lading or air waybill matching the importer of record.
  • FDA establishment registration number and device listing confirmation.
  • FDA product code and, where applicable, the 510(k) or PMA reference.
  • U.S. Agent designation letter and, where relevant, Initial Importer details.
  • Labeling that meets 21 CFR Part 801, including the name and place of business of the manufacturer, packer or distributor.

Step 3: Get labeling and UDI right before the goods move

Labeling problems are expensive to fix after arrival because corrections happen under quarantine, in a regulated facility, with documentation. Review the label artwork against Part 801 requirements and confirm UDI compliance for the device class, including the device identifier, production identifier and GUDID submission.

If a U.S.-specific label is required, the safest sequence is relabeling at a registered facility under a documented procedure, not in transit and not at a third-party printer whose records you cannot produce later.

Step 4: The entry at the port

The importer of record files the entry, usually through a customs broker, and FDA reviews it electronically. Most entries clear within a day or two. A first entry using a new registration, or a device FDA has not reviewed before, is more likely to be flagged for further review or examination, and the response window is short.

This is where having a U.S. party who can answer FDA questions matters most. A designation letter does not by itself produce a same-day response in your time zone.

Step 5: After release

Once released, the device needs compliant storage, distribution records and a post-market process: complaint intake, reportability assessment, MDR filing where required, and correction or removal reporting. Those obligations attach to the device from the first U.S. sale, not from the first recall.

Need this applied to your device?

We run U.S. entry, warehousing, fulfillment and post-market support for medical device manufacturers. Bring the specifics and we will map the steps.